Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis.

about

The paradigm shift to end tuberculosis. Are we ready to assume the changes?The burden of multidrug-resistant tuberculosis in children.Is Chemoprophylaxis for Child Contacts of Drug-Resistant TB Patients Beneficial? A Systematic Review.

P2860

Q38676708-9608D0B4-2ABB-4AEF-8D57-19A804191D09 Q53694397-5E771738-5721-4654-9D1E-DA9CB0111E84 Q55154652-E8205BCC-99EA-4C74-A0B7-23A24B22F687

P2860

Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis.

Item

http://www.wikidata.org/entity/Q38886442

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Systematic Review, Meta-analys ...... tidrug-Resistant Tuberculosis.

@en

type

Item

label

Systematic Review, Meta-analys ...... tidrug-Resistant Tuberculosis.

@en

prefLabel

Systematic Review, Meta-analys ...... tidrug-Resistant Tuberculosis.

@en

P1476

Systematic Review, Meta-analys ...... tidrug-Resistant Tuberculosis.

@en

P2093

Sapna Bamrah Morris

http://www.w3.org/2001/XMLSchema#string

Sundari R Mase

http://www.w3.org/2001/XMLSchema#string

Suzanne M Marks

http://www.w3.org/2001/XMLSchema#string

P2860

Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosis

Estimating tuberculosis cases and their economic costs averted in the United States over the past two decades

Strategies for treating latent multiple-drug resistant tuberculosis: a decision analysis

Treatment of latent tuberculosis in persons at risk for multidrug-resistant tuberculosis: systematic review.

Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005-2007.

Adverse events associated with pyrazinamide and levofloxacin in the treatment of latent multidrug-resistant tuberculosis.

Limited tolerability of levofloxacin and pyrazinamide for multidrug-resistant tuberculosis prophylaxis in a solid organ transplant population.

Adverse events in healthy individuals and MDR-TB contacts treated with anti-tuberculosis drugs potentially effective for preventing development of MDR-TB: a systematic review.

Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA.

Contact investigations as a means of detection and timely treatment of persons with infectious multidrug-resistant tuberculosis.

P304

1670-1677

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1093/CID/CIX208

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28329197

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

multiple drug resistance

P932

5543758

http://www.w3.org/2001/XMLSchema#string

Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis.

about

P2860

P2860

Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932